Articles tagged "Vaccination"

2019 American Transplant Congress
Immunization Status at the Time of Pediatric Liver Transplant: A 1-year Study through The Society of Pediatric Liver Transplantation
A. G. Feldman¹, A. Kempe², B. L. Beaty³, R. Torres¹, D. Curtis⁴, S. S. Sundaram¹
¹Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado, Aurora, CO, ²Pediatrics, University of Colorado, Aurora, CO, ³University of Colorado, Aurora, CO, ⁴Pediatric Infectious Diseases, University of Colorado, Aurora, CO
*Purpose: Vaccine preventable infections are a serious and common complication following transplant. Immunizations are a minimally invasive and cost-effective approach to reducing infections. The objectives…
2019 American Transplant Congress
Barriers to Pre-Transplant Immunization: A Qualitative Study of Pediatric Liver-Transplant Stakeholders
A. G. Feldman¹, R. Marsh², A. Kempe³, M. Morris²
¹Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado, Aurora, CO, ²University of Colorado, Aurora, CO, ³Pediatrics, University of Colorado, Aurora, CO
*Purpose: Less than 30% of pediatric liver transplant recipients are up-to-date on age-appropriate immunizations at the time of transplant despite being at high-risk for infections…
2019 American Transplant Congress
Impact of Preoperative Rifaximin Use on Reducing Graft Injury in Liver Transplantation: A Propensity Matched Analysis
T. Ito, K. Nakamura, S. Kageyama, H. Hirao, K. Kadono, J. Aziz, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, J. Kupiec-Weglinski, F. M. Kaldas
Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Intestinal microbiota are thought to play an important role in affecting the multifactorial and complex mechanisms of hepatic ischemia reperfusion injury (IRI) after liver…
2019 American Transplant Congress
Evaluation of Influenza Virus Antibody Response in Naturally Infected and Vaccinated Transplant Recipients by Protein Microarray
C. Hirzel, A. Chruscinski, V. H. Ferreira, A. G. L'Huillier, A. Humar, D. Kumar
University Health Network, Toronto, ON, Canada
*Purpose: Influenza A virus (IAV) infection is known to be an important cause of morbidity in solid organ transplant (SOT) recipients. The objective of our…
2019 American Transplant Congress
A Comparison of Cell-Mediated Immune Responses among Organ Transplant Recipients Receiving High-Dose vs Standard-Dose Influenza Vaccine
A. G. L'Huillier, V. H. Ferreira, Y. Natori, T. Ku, C. Hirzel, M. Ierullo, A. Humar, D. Kumar
University Health Network, Toronto, ON, Canada
*Purpose: The High-dose (HD) influenza vaccine has been shown to induce better humoral immunity than the standard-dose (SD) vaccine in solid organ transplant (SOT) patients.…
2019 American Transplant Congress
Vaccination Rates and Relation to Health Beliefs in Inner-City Kidney Transplant Recipients (KTRs)
Y. Akivis, J. Leong, I. Rosenstein, A. Myrie, M. Moy, M. Markell
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Prophylaxis against viral and bacterial infections as outlined by guidelines issued by the 2013 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for…
2019 American Transplant Congress
A CMV Vaccine Based on Non-Replicating Lymphocytic Choriomeningitis Virus Vectors Expressing gB and pp65 is Safe and Immunogenic in Healthy Volunteers and Entering a Phase 2 Trial in Kidney Transplant Recipients
C. N. Kotton¹, M. Schwendinger², G. Thiry³, B. De Vos⁴, F. De Boever⁵, G. Leroux-Roels⁶, A. Lilja⁷
¹Infectious Diseases Division, Boston, MA, ²Hookipa Biotech AG, Vienna, Austria, ³Hookipa Biotech GmbH, VIenna, Austria, ⁴Bejamad sprl/bvba, Beersel, Belgium, ⁵Centrum voor vaccinologie (CEVAC), Gdent, Belgium, ⁶Centrum voor vaccinologie (CEVAC), Gent, Belgium, ⁷Hookipa Biotech GmbH, Vienna, Austria
*Purpose: Cytomegalovirus (CMV) is a significant pathogen in pregnancy and immunocompromised patients. Antiviral prophylaxis is limited by toxicities, recurrent infection, and resistance. A safe and…
2019 American Transplant Congress
Vaccine Response as a Predictor of Kidney Transplant Rejection and Serious Infection
A. Ta'eed, K. R. Polkinghorne, W. R. Mulley
Department of Nephrology, Monash Health, Clayton, Australia
*Purpose: Vaccination generates immune memory, including antibodies against harmful pathogens. Transplant immunosuppression prevents similar processes occurring against alloantigens. Transplant recipients have significantly reduced seroresponses to…
2019 American Transplant Congress
A Nurse-Driven Influenza Vaccine Ordering Protocol Improves Vaccination Rates in Abdominal Organ Transplant Recipients
T. Ho¹, C. D. Sifri², J. D. Lewis³
¹Department of Medicine, Virginia Commonwealth University, Richmond, VA, ²Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, ³Division of Infectious Diseases, Medical University of South Carolina, Charleston, SC
*Purpose: Solid organ transplant (SOT) recipients are at increased risk of influenza infection and severe influenza-related complications. The influenza vaccine is a safe and effective…
2019 American Transplant Congress
Need For Protocol Driven Mmr/vzv Serologic Screening
A. Agarwal¹, L. Brumble¹, H. Wadei², C. Libertin¹
¹Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Jacksonville, FL, ²Department of Transplant, Mayo Clinic, Jacksonville, FL
*Purpose: The current American Society of Transplantation-ID guidelines recommend the MMR and VZV serologic screening pre transplantation for of all persons born after 1956. MMR…